ImmuCell Corp ICCC:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 1:27 PM EST
9.30quote price arrow up+0.22 (+2.47%)
Volume
15,856
52 week range
3.70 - 13.20

...

Loading . . .

KEY STATS

  • Open9.08
  • Day High9.30
  • Day Low9.00
  • Prev Close9.08
  • 52 Week High13.20
  • 52 Week High Date01/29/21
  • 52 Week Low3.70
  • 52 Week Low Date04/06/20
  • Market Cap67.08M
  • Shares Out7.21M
  • 10 Day Average Volume0.05M
  • Dividend-
  • Dividend Yield-
  • Beta0.93
  • 1 Year % Change85.64

RATIOS/PROFITABILITY

  • EPS (TTM)-0.14
  • P/E (TTM)-65.66
  • Fwd P/E (NTM)-71.57
  • EBITDA (MRQ)1.07M
  • ROE (MRQ)-5.32%
  • Revenue (MRQ)15.34M
  • Gross Margin (MRQ)44.73%
  • Net Margin (MRQ)-6.66%
  • Debt To Equity (MRQ)34.68%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest ImmuCell Corp News

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
ImmuCell Corporation is an animal health company. The Company operates in the development, acquisition, manufacture and sale of products that improve the health and productivity of cows for the dairy and beef industries segment. The Company has developed products that provide immediate immunity to newborn dairy and beef cattle, and is developing product line extensions of its existing products that address mastitis. The Company's lead product, First Defense, is manufactured...
David Tomsche
Chairman
Michael Brigham
President
Bobbi Brockmann
Vice President
Elizabeth Williams
Vice President
Address
56 Evergreen Dr
Portland, ME
04103-1066
United States